BlackRock Capital Allocation Term Trust (BCAT) Stock
2 of the hedge funds AlphaScala tracks reported BCAT in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $309.1K.
Which hedge funds own BCAT?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 19K | $309.1K | -78% |
| Millennium Management Israel Englander | 12K | $195.0K | -36% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →BCAT price chart
Powered by TradingViewWhat does BlackRock Capital Allocation Term Trust do?
BlackRock Capital Allocation Trust is a closed-end investment fund managed by BlackRock, one of the world’s largest asset managers. Its primary function is to provide investors with total return and income through a dynamically balanced mix of global equities, fixed income instruments, and private investments. The fund typically maintains a diversified allocation, with a notable recent split of approximately 55% equity and 45% fixed income. It also seeks meaningful exposure to private equity and private credit, with a portion of assets dedicated to innovative sectors such as technology and medical devices. BlackRock Capital Allocation Trust stands out for its unconstrained, multi-asset approach, allowing portfolio managers to adjust allocations opportunistically based on evolving market conditions. Over time, the strategy has included both U.S. and non-U.S. securities, aiming for risk-adjusted returns by combining liquid assets with selected private investments. The trust incorporates risk management tools and periodic share buyback programs, and it plans a liquidity event at net asset value in 2032. Altogether, it serves as a comprehensive solution for investors seeking diversified exposure to stock, bond, and private markets within a single investment vehicle.